United States Biosimilars Market Report 2016

Publisher Name :
Date: 10-Oct-2016
No. of pages: 116
Inquire Before Buying

Notes:

Sales, means the sales volume of Biosimilars

Revenue, means the sales value of Biosimilars

This report studies sales (consumption) of Biosimilars in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Roche

- Amgen

- AbbVie

- Sanofi-Aventis

- Johnson & Johnson

- Pfizer

- Novo Nordisk

- Eli Lilly

- Novartis

- Merck

- 3sbio

- Changchun High Tech

- CP Guojian

- Biotech

- Gelgen

- Innovent

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Antibody

- Hormone

- Growth Factors

- Others

Split by applications, this report focuses on sales, market share and growth rate of Biosimilars in each application, can be divided into

- Tumor

- Diabetes

- Cardiovascular

- Hemophilia

- Others

United States Biosimilars Market Report 2016

Table of Contents
United States Biosimilars Market Report 2016
1 Biosimilars Overview
1.1 Product Overview and Scope of Biosimilars
1.2 Classification of Biosimilars
1.2.1 Antibody
1.2.2 Hormone
1.2.3 Growth Factors
1.2.4 Others
1.3 Application of Biosimilars
1.3.1 Tumor
1.3.2 Diabetes
1.3.3 Cardiovascular
1.3.4 Hemophilia
1.3.5 Others
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Biosimilars (2011-2021)
1.4.1 United States Biosimilars Sales and Growth Rate (2011-2021)
1.4.2 United States Biosimilars Revenue and Growth Rate (2011-2021)
2 United States Biosimilars Competition by Manufacturers
2.1 United States Biosimilars Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Biosimilars Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Biosimilars Average Price by Manufactures (2015 and 2016)
2.4 Biosimilars Market Competitive Situation and Trends
2.4.1 Biosimilars Market Concentration Rate
2.4.2 Biosimilars Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Biosimilars Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Biosimilars Sales and Market Share by Type (2011-2016)
3.2 United States Biosimilars Revenue and Market Share by Type (2011-2016)
3.3 United States Biosimilars Price by Type (2011-2016)
3.4 United States Biosimilars Sales Growth Rate by Type (2011-2016)
4 United States Biosimilars Sales (Volume) by Application (2011-2016)
4.1 United States Biosimilars Sales and Market Share by Application (2011-2016)
4.2 United States Biosimilars Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Biosimilars Manufacturers Profiles/Analysis
5.1 Roche
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Biosimilars Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Roche Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Amgen
5.2.2 Biosimilars Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Amgen Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 AbbVie
5.3.2 Biosimilars Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 AbbVie Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Sanofi-Aventis
5.4.2 Biosimilars Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Sanofi-Aventis Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Johnson & Johnson
5.5.2 Biosimilars Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Johnson & Johnson Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Pfizer
5.6.2 Biosimilars Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Pfizer Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Novo Nordisk
5.7.2 Biosimilars Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Novo Nordisk Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Eli Lilly
5.8.2 Biosimilars Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Eli Lilly Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Novartis
5.9.2 Biosimilars Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Novartis Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Merck
5.10.2 Biosimilars Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Merck Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 3sbio
5.12 Changchun High Tech
5.13 CP Guojian
5.14 Biotech
5.15 Gelgen
5.16 Innovent
6 Biosimilars Manufacturing Cost Analysis
6.1 Biosimilars Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Biosimilars
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Biosimilars Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Biosimilars Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Biosimilars Market Forecast (2016-2021)
10.1 United States Biosimilars Sales, Revenue Forecast (2016-2021)
10.2 United States Biosimilars Sales Forecast by Type (2016-2021)
10.3 United States Biosimilars Sales Forecast by Application (2016-2021)
10.4 Biosimilars Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Biosimilars
Table Classification of Biosimilars
Figure United States Sales Market Share of Biosimilars by Type in 2015
Figure Antibody Picture
Figure Hormone Picture
Figure Growth Factors Picture
Figure Others Picture
Table Application of Biosimilars
Figure United States Sales Market Share of Biosimilars by Application in 2015
Figure Tumor Examples
Figure Diabetes Examples
Figure Cardiovascular Examples
Figure Hemophilia Examples
Figure Others Examples
Figure United States Biosimilars Sales and Growth Rate (2011-2021)
Figure United States Biosimilars Revenue and Growth Rate (2011-2021)
Table United States Biosimilars Sales of Key Manufacturers (2015 and 2016)
Table United States Biosimilars Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biosimilars Sales Share by Manufacturers
Figure 2016 Biosimilars Sales Share by Manufacturers
Table United States Biosimilars Revenue by Manufacturers (2015 and 2016)
Table United States Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Biosimilars Revenue Share by Manufacturers
Table 2016 United States Biosimilars Revenue Share by Manufacturers
Table United States Market Biosimilars Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Biosimilars Average Price of Key Manufacturers in 2015
Figure Biosimilars Market Share of Top 3 Manufacturers
Figure Biosimilars Market Share of Top 5 Manufacturers
Table United States Biosimilars Sales by Type (2011-2016)
Table United States Biosimilars Sales Share by Type (2011-2016)
Figure United States Biosimilars Sales Market Share by Type in 2015
Table United States Biosimilars Revenue and Market Share by Type (2011-2016)
Table United States Biosimilars Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Biosimilars by Type (2011-2016)
Table United States Biosimilars Price by Type (2011-2016)
Figure United States Biosimilars Sales Growth Rate by Type (2011-2016)
Table United States Biosimilars Sales by Application (2011-2016)
Table United States Biosimilars Sales Market Share by Application (2011-2016)
Figure United States Biosimilars Sales Market Share by Application in 2015
Table United States Biosimilars Sales Growth Rate by Application (2011-2016)
Figure United States Biosimilars Sales Growth Rate by Application (2011-2016)
Table Roche Basic Information List
Table Roche Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Biosimilars Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Biosimilars Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Biosimilars Sales Market Share (2011-2016)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi-Aventis Biosimilars Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Biosimilars Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Biosimilars Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Biosimilars Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Biosimilars Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Biosimilars Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Biosimilars Sales Market Share (2011-2016)
Table 3sbio Basic Information List
Table 3sbio Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table 3sbio Biosimilars Sales Market Share (2011-2016)
Table Changchun High Tech Basic Information List
Table Changchun High Tech Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changchun High Tech Biosimilars Sales Market Share (2011-2016)
Table CP Guojian Basic Information List
Table CP Guojian Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table CP Guojian Biosimilars Sales Market Share (2011-2016)
Table Biotech Basic Information List
Table Biotech Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biotech Biosimilars Sales Market Share (2011-2016)
Table Gelgen Basic Information List
Table Gelgen Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gelgen Biosimilars Sales Market Share (2011-2016)
Table Innovent Basic Information List
Table Innovent Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Innovent Biosimilars Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilars
Figure Manufacturing Process Analysis of Biosimilars
Figure Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biosimilars Major Manufacturers in 2015
Table Major Buyers of Biosimilars
Table Distributors/Traders List
Figure United States Biosimilars Production and Growth Rate Forecast (2016-2021)
Figure United States Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Table United States Biosimilars Production Forecast by Type (2016-2021)
Table United States Biosimilars Consumption Forecast by Application (2016-2021)
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Liquid Chromatography Detectors Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 109
    Liquid Chromatography Detectors is a device used in liquid chromatography (LC) to detect components of the mixture being eluted off the chromatography column. A broad range of detectors is available to meet different sample requirements. Specific detectors respond to a particular compound only and the response is independent of mobile phase composition. On the other hand the response of bulk property detectors is dependent on collective changes in composition of sample and mobile phase. ......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) IV Bags Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 103
    This report studies the IV Bag market including flex plastics bag, semi-rigid IV Bags, glass bottles. Scope of the Report: This report focuses on the IV Bags in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers - Baxter - SSY Group - ......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Fractional Flow Reserve Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 107
    Fractional flow reserve (FFR) is a technique used in coronary catheterization to measure pressure differences across a coronary artery stenosis (narrowing, usually due to atherosclerosis) to determine the likelihood that the stenosis impedes oxygen delivery to the heart muscle (myocardial ischemia). Scope of the Report: This report focuses on the Fractional Flow Reserve in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle Eas......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) ICAD (Intracranial Atherosclerotic Disease) Pathology Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 107
    Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Scope of the Report: This report focuses on the ICAD (Intracranial Atherosclerotic Disease) Pathology in Global market, especially in North America,......
  • North America and Europe APAC Hydrocolloid Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 105
    A hydrocolloid dressing is an opaque or transparent dressing for wounds. A hydrocolloid dressing is biodegradeable, non-breathable, and adheres to the skin, so no separate taping is needed. Scope of the Report: This report focuses on the APAC Hydrocolloid in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and appl......
  • North America and Europe APAC Silver Dressing Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 103
    Silver dressings are a relatively new family of advanced wound care dressings for the treatment of infected wounds. A silver dressing is a wound dressing impregnated with ionic silver. The ionic silver is responsible for the anti-microbial activity against infection caused by bacteria. Scope of the Report: This report focuses on the APAC Silver Dressing in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy an......
  • North America and Europe Breast Lesion Localization Methods Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 109
    This report studies the Breast Lesion Localization Methods market, including wire localization biopsy, radioisotope localization, magnetic tracer and other products. Scope of the Report: This report focuses on the Breast Lesion Localization Methods in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and application......
  • North America and Europe Casting and Splinting Products Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 105
    An orthopedic cast, or simply cast, is a shell, frequently made from plaster or fiberglass, encasing a limb (or, in some cases, large portions of the body) to stabilize and hold anatomical structures, most often a broken bone (or bones), in place until healing is confirmed. It is similar in function to a splint. Scope of the Report: This report focuses on the Casting and Splinting Products in North America and Europe market, especially in United States, United Kingd......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Oncolytic Virus Therapy Market 2018 Forecast to 2023
    Published: 27-Apr-2018        Price: US 4880 Onwards        Pages: 108
    Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn't until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs